Novozymes A/S | 422.10 / -3.54% |
Date/Time | 05/19 / 11:49 |
Chg. / Chg.(%) | -15.50 / -3.54% |
Bid | 422.00 / 38 |
Ask | 422.30 / 6 |
Open | 431.90 |
Previous Close | 437.60 |
High | 432.30 |
Low | 420.80 |
Volume [DKK] | 15,470,693.50 |
Volume [Units] | 103,520 |
Price fixings | 2270 |
ISIN | DK0060336014 |
Security | NZYMB/C |
Exchange | Cboe Europe DXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 422.10 | ![]() |
103,520 |
London Inter.. | 421.00 | ![]() |
4,972 |
Turquoise | 421.60 | ![]() |
4,093 |
TradeGate | 56.760 | ![]() |
449 |
gettex | 56.580 | ![]() |
305 |
Cboe Europe .. | 429.75 | ![]() |
151 |
Frankfurt | 57.2800 | ![]() |
0 |
München | 57.76 | ![]() |
0 |
Düsseldorf | 57.10 | ![]() |
0 |
Berlin | 57.16 | ![]() |
0 |
Vienna Globa.. | 57.58 | ![]() |
0 |
Quotrix | 58.1200 | ![]() |
|
Stuttgart | 57.840 | ![]() |
|
Lang & Schwa.. | 56.68 | ![]() |
|
OMX Nordic | 437.60 | ![]() |
295,182 |
Cboe Europe .. | 434.80 | 125 | |
Nasdaq Other.. | 60.6000 | 566 | |
Xetra | 59.36 | 5 | |
Mexico | 1,305.94 | ![]() |
728 |
News
- NMD Pharma Raises €35 Million in a new Financing
02/15/2022 / 13:00 - GlobeNewswire - NMD Pharma Raises €35 Million in a new Financing
02/15/2022 / 07:00 - GlobeNewswire - Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
02/01/2022 / 08:01 - GlobeNewswire - CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO
12/20/2021 / 14:30 - GlobeNewswire - Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹
12/16/2021 / 14:00 - GlobeNewswire